Eric Kimelblatt

Senior Director, Managed Markets
Artia Solutions

Eric is currently the Senior Director of Managed Markets, working with clients to effectively capitalize on opportunities and overcome challenges with Payers and PBMs in the Medicaid Managed Care, Medicare Part D and Commercial markets.

Achieving Successful Market Access in Medicaid Managed Care: A Dialog with MMC Executives
Tuesday, July 13
4:00 – 5:00 p.m.

VIEW AGENDA

Eric’s entire career has been focused on the government and commercial payer markets from a pharmaceutical manufacturer perspective, with a concentration on managed markets strategy, access/reimbursement, account management, pricing/contracting, patient support and product distribution.

Eric is currently in his fifth year as the Senior Director of Managed Markets for Artia Solutions, working with clients to effectively capitalize on opportunities and overcome challenges with Payers and PBMs in the Medicaid Managed Care, Medicare Part D and Commercial markets.

For more than five years, Eric served as Director of National Accounts for Gilead Sciences, with full accountability for the government payer segment (Veterans Administration, Medicaid, 340B, AIDS Drug Assistance Program), as well as PBMs and private payers/insurers (Commercial, Medicare Part D, Medicaid Managed Care, Health Exchanges). In addition, he was responsible for establishing and improving relationships with Specialty Pharmacy partners. During this time, Gilead launched Harvoni and Sovaldi for HCV, five combination products for HIV, and Zydelig for Oncology.

Eric’s previous role at Gilead was Director of Contracting and Pricing, where he led efforts to determine and implement optimal pricing strategies in each market segment, while ensuring compliance with government program rules and regulations. He also provided expertise in assessing the impact of market dynamics as well as new legislation, including the Affordable Care Act (ACA) and the Deficit Reduction Act (DRA).

Eric previously held a similar position at Cephalon Pharmaceuticals. In these roles, he provided significant support to the National Account teams to help further customer relationships by proactively and collaboratively developing solutions to issues that inherently arise in these complex and critical markets. During this time, he helped support the launches of Letairis for PAH, Cayston for CF and Viread for HBV.

Prior to Gilead, Eric spent several years as a Principal Consultant with IMS Health in the areas of government/commercial strategy, pricing, contracting and compliance. While at IMS Health, he also specialized in wholesaler/trade relations and conducted inventory management audits and operational assessments of wholesalers on behalf of manufacturers. Originally from Bethesda, MD, Eric holds a Bachelor of Science degree in economics from the Wharton School at the University of Pennsylvania.

Eric holds a Bachelor of Science degree in economics from the Wharton School at the University of Pennsylvania.

education

Learn more about our Crossroads 2021 Speakers!

Brad Burris

Ross Margulies

Terry Cothran

Katie Lapins Trujillo

Joshua Moore

See All Speakers

The South Carolina Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education credits will be available to participants who fully attend the program and then complete an online educational activity evaluation. A unique code given at each activity must be provided in the evaluation to receive credit. Grievances regarding the education program must be submitted in writing to the SCPhA ACPE Administrator immediately following the program.